SCOPE Summit for Clinical Ops Executives
Talk Digital Health Technologies track
The Future of Regulatory Acceptance of Digital Measures Is Happening Now: Continuing the Journey
Thu, Feb 6, 2025 · 8:25–8:50 AM EST Rosen Shingle Creek
About this session
Digital measures can enhance drug development by potentially unlocking new ways of measuring efficacy and safety for medicinal products. The regulatory pathways for digital measures in R&D are emerging along with regulatory guidance on evidence generation of digital endpoints. To ensure the successful use of digital measures in R&D, these need to be further shaped to accelerate implementation of digital measures in R&D in drug development and health authority acceptance.
